IP Verse

Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement - EP3167888

PATENT ANALYSIS

Patent Details

Grant Date
May 1, 2024
Company
ALEXION PHARMACEUTICALS, INC.
Oppositions

SAMSUNG BIOEPIS NL B.V.

More patents of Alexion Pharmaceuticals, Inc.

EP3167888

EP2894165

EP2978451

Want to monitor this patent?

Feel free to send us a message here and we will get back to you